MedPath

Impact of COVID-19 on children and adolescents with autism spectrum disorder (ASD) and their families

Recruiting
Conditions
autism spectrum disorder
autism
10012562
Registration Number
NL-OMON54902
Lead Sponsor
Erasmus Universiteit Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
68
Inclusion Criteria

1) child is between the ages of 4 to 21 years old;
2) there is a clinical diagnosis of ASD;
3) there are measurements available pre-COVID-19 measures (either intake or
ROM-data)

Exclusion Criteria

1) parent and/or client do not master the Dutch language sufficiently to be
able to participate
2) parent/client cannot or will not give informed consent for participation.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primairy outcome variables are:<br /><br>- General functioning:<br /><br>o Child Behavior Checklist (CBCL): T0 vs. T1 vs. T2<br /><br>o Youth Self Report (YSR): T0 vs. T1<br /><br>- Autism characteristics:<br /><br>o Social Responsiveness Scale (SRS-2/SRS-A): T0 vs. T1 vs. T2<br /><br><br /><br>- Individual parent interviews to chart family functioning and (current) care-<br /><br>and informational needs.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Quality of life of the child (PedSQL): T1 vs. T2<br /><br>- Impact of COVID-19: e.g. behavior, stress, anxiety; atmosphere at home,<br /><br>effect on child: T1 vs. T2<br /><br>- Parenting load (OBVL): T1 vs. T2</p><br>
© Copyright 2025. All Rights Reserved by MedPath